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In this issue of EJAP, Johnston et al. (2018) report on the ergogenic aid of nicotine to
enhance anaerobic performance in nicotine-naïve individuals. Here, the authors find that
following oral consumption of 5 mg of nicotine, athletes who are nicotine naïve significantly
increased their peak (and average) power output, as well as heart rate and blood pressure,
which they attribute to nicotine’s sympathomimetic effect. While these are not the first data
to make such an observation, the current study is notable for using a randomized, doubleblind, cross-over design that delivered nicotine (or flavor-matched placebo) via orallydispensed strips. It should be noted that the benefits of nicotine to athletic performance has
been somewhat controversial, as some studies show benefits (e.g. Mündel and Jones 2006)
whilst many others show marginal to no benefit (e.g. Fogt et al. 2016). But, most of the
existing studies have significant limitations (such as lack of determination of nicotine levels
as a manipulation check, lack of participant blinding or suitable placebo-control, and more
tolerable delivery systems with fewer side-effects) leaving clear and robust interpretation of
nicotine effects often difficult to make. Based on the strength of the current study design,
these data certainly add credence to the potential benefit(s) of nicotine for repeated bouts of
anaerobic exercise, and will likely embolden athletes to want to use nicotine to achieve that
extra edge during athletic events. At present, professional anti-doping bodies do not ban
nicotine, and so its use and interest among athletes is likely to increase. While the data by
Johnston et al. provide robust evidence of the benefits of nicotine on repeated anaerobic
performance, there are several points to further consider before athletes (particularly nicotine
naïve) choose to take nicotine.
First, nicotine is among the most addictive substances known to man, and there is a wide
variation in individuals’ tolerance and sensitivities to nicotine, such that some users may
require increasing usage/dosage and develop greater dependence with increasing regularity
of use. This could itself cause either depressive (at higher doses of nicotine) or inhibitory
(with increased tolerance) effects that could lead to an ergolytic impact.
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Second, timing of nicotine consumption and the influence of, for example, nutrition (meals,
ingredients such as menthol or grapefruit) will likely alter the rate of nicotine clearance,
reducing or delaying the maximal effect observed. Women, including those taking oral
contraception, and those of certain ethnicities will metabolize nicotine differently from a
Caucasian male. Thus far, existing studies have been limited to young, healthy males.
Third, exercise is often performed under conditions of thermal stress (whether outdoors in
the heat, or indoors with restrictive clothing and/or without suitable air-conditioning). Whilst
nicotine is known to reduce skin blood flow, this combination could have undesired effects
leading to hyperthermia.
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Finally, the delivery method is likely to be critically important and have a significant
influence on the potential outcomes. While patches, gum, and/or orally dissolved strips are
undoubtedly the ‘cleanest’ method for delivering nicotine, they each possess their own
limitations in optimal systemic drug delivery (Mündel 2017) that may limit the desired
performance outcomes. The development of electronic nicotine delivery systems, more
commonly known as electronic cigarettes (E-cigarettes), provides another new and rapid
delivery method that may be appealing to some, particularly younger athletes. However, it
should be noted that emerging evidence suggests that E-cigarettes are unlikely to be riskfree, and likely pose greater pulmonary (Chun et al. 2017) and cardiovascular (Olfert et al.
2017) risks than that which is currently being advertised. Whether the observed pulmonary
and vascular dysfunction is due to nicotine or some other component of the liquid (e.g.
carbonyl compounds, metals, etc.) is not yet fully understood, but this topic is of great
interest and under active investigation. Moreover, since E-cigarettes have only been around
for little over a decade, the overall long-term health effects in humans are entirely unknown.
But, if animal exposure studies are a harbinger for chronic vaping in humans (as they have
historically been shown for exposure to cigarette smoke), recent evidence indicates that even
relatively low levels of chronic E-cigarette vapor increases arterial stiffness and reduces
vascular reactivity, both of which are considered early pre-clinical indicators and hallmark
evidence in the development/progression of cardiovascular disease.
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While Johnston et al. (2018) have provided tantalizing and robust data that can paint nicotine
as another tool in an athlete’s arsenal, these data only emphasize the need for further
rigorous investigations determining the magnitude and under what conditions nicotine
enhances sports performance; this is especially the case as a reported 25–50% of team/
strength athletes actively consume nicotine in-competition. Notwithstanding any potential
short-term benefit in performance that may exist for some sporting activities, these gains
may be short-sighted when weighed against the highly addictive nature of nicotine and the
potential curse of dependence over a lifetime. Moreover, depending on the route of delivery
(such as with E-cigarettes), the risk toward long-term health is still poorly determined.
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